Aignostics secures $34 million Series B to improve precision medicine with AI

Investments will support new product offerings, US expansion, and development of pathology foundation models

05-Nov-2024 - Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...

Data-efficient foundation model for biomarker detection

Artificial intelligence for clinical pathology: A new multi-task approach

04-Sep-2024 - The use of Artificial Intelligence (AI) systems shows promise in medicine, where they can be used to detect diseases earlier, improve treatments, and ease staff workloads. But their performance depends on how well the AI is trained. A new multi-task approach to training AI makes it possible to ...

LMU research transfer: several start-ups attract 7-figure investments

In successful funding rounds, three LMU spin-offs have brought in investments worth millions.

25-Jun-2024 - Tubulis, Smart Reporting, and Eisbach Bio have successfully attracted new investor funding. The new capital will enable the companies, for example, to expand their research and development activities. Tubulis and Eisbach develop new therapeutic approaches and active agents for cancer treatment, ...

AI for medical documentation is a rapidly growing future market

Smart Reporting successfully closes financing round for 23 million euros

24-Apr-2024 - Smart Reporting has successfully completed a financing round of 23 million euros. TVM Capital Life Science (lead investor) and Bayern Kapital are newly on board in the Series C funding, while the existing investors are also participating in the financing round. The capital raised will primarily ...

Spin-off from Charité want to advance AI-powered pathology

Aignostics Raises €5 Million Seed Round

31-Aug-2020 - Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the round, ...

Peripheral Induction of Alzheimer-Like Brain Pathology in Mice

25-Oct-2010 - Pathological protein deposits linked to Alzheimer's disease and cerebral amyloid angiopathy can be triggered not only by the administration of pathogenic misfolded protein fragments directly into the brain but also by peripheral administration outside the brain. This is shown in a new study done ...

Immune Cells Also Attack Neurons Directly

New Findings on Multiple Sclerosis

24-Sep-2010 - Researchers in Germany have gained new insight into how the immune system causes damage associated with multiple sclerosis (MS), an incurable neuroinflammatory disorder. Using imaging tools which enable investigation of processes in living organisms, they were able to show a direct interaction ...

Multiple sclerosis: T cells as serial killers

16-Oct-2009 - In multiple sclerosis, the immune system also damages the nerve cells with its misguided activities. This is what regularly happens in the targeted immunological attack on the myelin sheaths of the nerve cells, as shown experimentally for the first time by researchers from Würzburg and ...

Together they make you ill

27-Jul-2009 - There are still gaps in our knowledge about the origin and course of complex diseases like multiple sclerosis. Now, researchers of the University of Würzburg have studied the interaction between two important factors - with a clear result. Chronic inflammatory diseases of the central nervous ...

New Mechanism for Cardiac Arrhythmia discovered

01-Oct-2008 - It has long been thought that virus infections can cause cardiac arrhythmia. But why has not been understood. Ulrike Lisewski, Dr. Yu Shi, Michael Radke and Professor Michael Gotthardt of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now discovered the molecular ...